Xabier Agirre

27PUBLICATIONS
135CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 02, 2026
A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities.

|Jul 02, 2026
Multiple myeloma: A tale of deregulated transcription factors.

|Jun 23, 2026
Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

|Jun 05, 2026
IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

|Sep 19, 2025
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Flor Navarro, Teresa Lozano, Andrea Fuentes-García

|Nov 03, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.

Francisco Exposito, Miriam Redrado, Diego Serrano

Pageof 5

Frequent Collaborators

21 joint publications

Felipe Prósper

6 joint publications

Luis Vitores Valcárcel

6 joint publications

José Ignacio Martin-Subero

5 joint publications

Patxi San-Martin